Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morissens

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Clinica Belgica|January 1, 1992
Doxycycline and hepatotoxicityF Lienart, M Morissens, P Jacobs, et al.
Revue Medicale De Bruxelles|August 1, 2009
[Cor triatriatum in the adult]A Wailliez, P Wauthy, P Decoodt, et al.
Revue Medicale De Bruxelles|November 1, 2011
[Management of atrial fibrillation in 2011]E Catez, B Sina, P De Coodt, et al.
International Journal of Cardiology|July 17, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide studyH Yang, B J Bouma, K Dimopoulos, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Clinica Belgica|January 1, 1992
Doxycycline and hepatotoxicityF Lienart, M Morissens, P Jacobs, et al.
Revue Medicale De Bruxelles|August 1, 2009
[Cor triatriatum in the adult]A Wailliez, P Wauthy, P Decoodt, et al.
Revue Medicale De Bruxelles|November 1, 2011
[Management of atrial fibrillation in 2011]E Catez, B Sina, P De Coodt, et al.
International Journal of Cardiology|July 17, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide studyH Yang, B J Bouma, K Dimopoulos, et al.
Pageof 1